ABSTRACT
INTRODUCTION
Nosocomial infections are infections acquired during hospital care, which are not present or incubating at admission, occurring more than 48 hours after admission. Important factors influencing nosocomial infection include old age, immune status, immunosuppressive drugs, underlying disease, injuries to skin, diagnostic and therapeutic interventions. 1 Skin and soft tissue infections (SSTIs) such as impetigo and erysipelas, 2 are one of the most frequent nosocomial infections found. 1 Erysipelas is usually caused by Staphylococcus aureus (S. aureus) or beta-hemolytic Streptococci. 2 The etiology of SSTIs may be normal host flora transferred through a break in the barrier, such as instrumentation (eg, needles), that could permit the entry of normal skin flora and indigenous flora from the instrument of penetration. 3 Esmaili et al. 4 reported that S. aureus responsible for 93,7% of skin infections in pemphigus patients.
Pemphigus foliaceus is an autoimmune disorder, with generalized crusts and erosion as clinical findings, and immunosuppressive drugs as the mainstay of treatment. 5 Hospitalization in addition to corticosteroid therapy (with or without adjuvant immunosuppressive agents) would predispose the pemphigus patients to infection, with skin infection as one of the most frequently acquired. 4 This is a case report of nosocomial infection manifested as erysipelas in a patient under immunosuppressive therapy.
CASE
A 57 year-old man was hospitalized at Department of Dermatology and Venereology, Dr. Hasan Sadikin Hospital, Bandung, Indonesia with pemphigus foliaceous (PF). The clinical findings were generalized erythema, superficial loose blisters, erosions, and crusts, that affect 70% of body surface area. Histopathology examination showed subcorneal acantholysis, and direct immunofluorescence revealed intra epidermal IgG deposition, thus the diagnosis was established. The patient was treated with 15 mg intravenous dexamethasone injection daily, along with intravenous ranitidine injection, and antihistamine.
On the 9th day of hospitalization, the patient complained about a painful, erythematous macules and edema on the upper right arm. There was history of repeated needle puncture, due to multiple failed trials of blood aspiration the day before, just below the site of the edema. From the physical examination, besides the generalized erythema and crusts, on the right arm there were irregular, well defined, painful erythema and edema with blisters and pustules on top, measuring 10 x 15 cm, that felt firm and warm on palpation ( Figure 1 ).
The blisters and pustules were aspirated for Gram staining, that revealed Gram (+) cocci and polymorphonuclear cells. Blood examination showed leukocytosis (28,400/mm 3 ).
Thus the erysipelas diagnosis was added, and considered as a nosocomial infection. The patient then given 2 grams intravenous ceftriaxone injection daily for 7 days, and wet compress with saline solution was applied to the erysipelas lesion. Improvement on the erythema and edema was seen the day after.
The patient was discharged from the hospital on the 12 th day, with improvement on the PF lesions, all the erosions have dried, and most of the crusts dissapeared. The erysipelas lesion was also improved, marked as decreased erythema and edema, and the pain diminished. After discharged from the hospital, the PF treatment was changed into 80 mg methylprednisolone tablet, to be tappered every 7 days. The erysipelas treatment was saline wet compress. Seven days later on the next visit, the PF lesions already became hyperpigmented macules, and the painful erysipelas lesion had already dissapeared. 
DISCUSSION
Skin and soft tissue infection is one of the most frequent nosocomial infections found. Injuries to skin or mucous membranes due to diagnostic or therapeutic interventions could bypass natural defense mechanism of the skin. Other factors including old age that are associated with decreased resistance to infection, and immunosuppressive drugs that may lower the resistance to infection. 1 Erysipelas is an SSTIs caused by S. aureus or beta-hemolytic Streptococci, 2 with bimodal incidence There is also an increased risk in the immunocompromised, including patients underwent corticosteroid therapy. Erysipelas diagnosis is largely based on clinical findings, and might demonstrate leukocytosis. 6 counted 20,000/ mm 3 or more. 7 The unique signs of erysipelas are welldemarcated erythema and edema, of which a diagnosis can be made confidently, and bullae or vesicles may complicate about 5% cases. The most commonly involved site was the leg, followed by the arm, and face. 8 The clinical findings of erysipelas in this case were tender, well-defined erythema and edema that felt warm on palpation, with blisters and pustules on top. There was also leukocytosis (28,400/mm 3 ). In this case, erysipelas was considered as nosocomial infection, as the patient acquired it on the 9 th day of hospitalization, and there were no signs of infection on admission. The predisposing factors were old age and corticosteroid consumption for PF treatment.
Conditions that lead to disruption in the skin barrier predisposed patients to erysipelas. 8 The etiology of skin and soft tissue infection may be normal host flora, with several means in penetrating the skin barrier. The most common route is through a break in the barrier, such as instrumentation (eg, needles), that could permit the entry of bacteria from the instrument of penetration. 3 In this case, multiple puncture wound from repeated trials of blood aspiration with needle the day before, on the site of erysipelas precipitated the disease.
Antibiotics are the mainstay of treatment for erysipelas and most patients experience a complete recovery after antibiotics and few experience recurrences. 6 A series of antibiotics have been suggested with highly successful clinical response, above 88%. 9 Ceftriaxone is a third generation cephalosporin, with SSTIs as one of the indications. 10 Based on the bacterial susceptibility data to antibiotics in Dr. Hasan Sadikin Hospital, ceftriaxone is still sensitive in 100% cases. 11 Pavlov and Slavova 12 reported that 3 rd generation cephalosporin given in a parenteral route for 5-7 days showed good clinical resolution in severe erysipelas. Clinical improvement will be seen in 24-48 hours after treatment initiation, and several days usually needed for disease resolution. 7 In this case, the blisters are aspirated while keeping the roof intact. Intravenous ceftriaxone as the mainstay treatment. The skin lesions improved within 24 hours and complete resolution was seen on the 14 th day.
Hospital-acquired infections add to functional disability and emotional stress of the patient and may, in some cases, lead to disabling conditions that reduce the quality of life. Nosocomial infections are also one of the leading causes of death. The economic costs are considerable. The increased length of stay for infected patients is the greatest contributor to cost. 1 Prevention of nosocomial infections requires integrated, monitored programs, which includes the following key components; 1) limiting transmission of organisms between patients in direct patient care through adequate hand washing and glove use, and appropriate aseptic practice, isolation strategies, sterilization and disinfection practices, and laundry, 2) controlling environmental risks for infection, 3) protecting patients with appropriate use of prophylactic antimicrobials, nutrition, and vaccinations, 4) limiting the risk of endogenous infections by minimizing invasive procedures, and promoting optimal antimicrobial use, 5) surveillance of infections, identifying and controlling outbreaks, 6) prevention of infection in staff members, and 7) enhancing staff patient care practices, and continuing staff education. 13 As a conclusion, puncture wound and immunosuppresive treatment could cause erysipelas as a nosocomial infection, and an appropriate treatment of the infection would decrease the functional disability of the patient.
